A Study to Learn About the Study Medicines (Nirmatrelvir Plus Ritonavir) in People Aged 12 Years or Older With COVID-19 and a Compromised Immune System
Clinical trial NCT05438602 · COMPLETED
Trial details
- NCT number
- NCT05438602
- Sponsor
- Pfizer
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-08-03
- Primary completion
- 2023-07-17
- Enrollment
- 158
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.